Brainstorm Cell Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $29.0K | $187.0K | $1.3M | $772.0K | $18.9M | $37.8M | $536.0K | $942.0K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $307.0K | $385.0K | $1.9M | $3.1M | $23.3M | $43.2M | $3.4M | $10.3M |
| Property, Plant & Equipment | $235.0K | $434.0K | $686.0K | $933.0K | $1.2M | $1.1M | $960.0K | $651.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.0M | $1.8M | $4.2M | $8.5M | $29.3M | $51.3M | $6.5M | $11.2M |
| Liabilities | ||||||||
| Accounts Payable | $7.1M | $6.1M | $5.0M | $6.2M | $3.7M | $5.4M | $14.7M | $4.5M |
| Total Current Liabilities | $11.0M | $9.0M | $7.8M | $8.8M | $6.3M | $11.2M | $17.7M | $6.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $11.0M | $9.6M | $9.1M | $11.5M | $9.9M | $15.8M | $18.8M | $6.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-236.9M | $-226.6M | $-215.0M | $-197.8M | $-173.5M | $-149.1M | $-117.3M | $-94.0M |
| Total Stockholders' Equity | $-10.0M | $-7.8M | $-4.9M | $-3.0M | $19.3M | $35.5M | $-12.2M | $5.0M |